Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment.
Repository Usage Stats
With insufficient access to treatment and a tradition of criminalizing addiction, people with substance use disorders - including opioid dependence - are more likely to be incarcerated than they are to receive the treatment they need. Drug treatment courts aim to address this problem, engaging their participants in substance use treatment in lieu of incarceration. Drug courts offer an especially important window of opportunity to connect opioid-dependent participants to extended-release naltrexone (XR-NTX), at a time when they are under highly-structured court supervision and required to detoxify from opioids to participate. Given the high cost of XR-NTX and high rates of uninsurance in the drug court population, new rigorous cost-effectiveness evidence is needed to demonstrate the extent to which XR-NTX improves program outcomes, including by reducing recidivism. With that new evidence, drug courts and the counties in which they are situated can make informed and difficult policy decisions about funding XR-NTX for some of their highest-risk community members.
Published Version (Please cite this version)10.1016/j.jsat.2017.02.016
Publication InfoRobertson, Allison Gilbert; & Swartz, Marvin Stanley (2017). Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment. J Subst Abuse Treat. 10.1016/j.jsat.2017.02.016. Retrieved from http://hdl.handle.net/10161/13938.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Associate Professor in Psychiatry and Behavioral Sciences
Research interests include mental health and substance abuse services and policy; links between mental illness, substance abuse and criminal justice involvement; effectiveness of criminal diversion and prison re-entry programs for adults with serious mental illness; and other legal and policy mechanism as mental health interventions.
Professor in Psychiatry and Behavioral Sciences
My major research interest is in examining the effectiveness of services for severely mentally ill individuals, including factors that improve or impede good outcomes. Current research includes: the effectiveness of involuntary outpatient commitment, psychiatric advance directives, criminal justice outcomes for persons with mental illnesses, violence and mental illness and antipsychotic medications. I also served as member of the MacArthur Foundation Research Network on Mandate
Alphabetical list of authors with Scholars@Duke profiles.